# Logos Global Management LP 13F Q2 2026: $2.3 billion

Logos Global Management LP reported $2.3 billion in 13F securities across 68 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Erasca Inc at $223 million, 9.6% of the reported value. Since Q1 2026 it opened 25 new positions and exited 23.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $2,322,922,487
- Positions: 68
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1792126
- Form 13F file number: 028-20025
- CRD number: 305162
- Business address: 1 Letterman Drive BLDG C, Suite C3-350, San Francisco, CA 94129
- SEC filing: [0001172661-26-003529](https://www.sec.gov/Archives/edgar/data/1792126/000117266126003529/0001172661-26-003529-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/logos-global-management-l-p-305162)

## Top 25 holdings by value

The largest of 68 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Erasca Inc](https://specstream.ai/data/institutional-holders/erasca-inc-29479a108) | COM | 12,150,000 | $222.6 million | +1,000,000 |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 1,024,000 | $136.5 million | +349,000 |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 700,000 | $131.1 million | -1,300,000 |
| [Ideaya Biosciences Inc](https://specstream.ai/data/institutional-holders/ideaya-biosciences-inc-45166a102) | COM | 3,000,000 | $111.8 million | -450,000 |
| [Biontech Se](https://specstream.ai/data/institutional-holders/biontech-se-09075v102) | SPONSORED ADS | 1,015,000 | $94.4 million | New |
| [Vera Therapeutics Inc](https://specstream.ai/data/institutional-holders/vera-therapeutics-inc-92337r101) | CL A | 2,200,000 | $94.4 million | New |
| [Tango Therapeutics Inc](https://specstream.ai/data/institutional-holders/tango-therapeutics-inc-87583x109) | COM | 2,850,000 | $89.1 million | -150,000 |
| [Praxis Precision Medicines I](https://specstream.ai/data/institutional-holders/praxis-precision-medicines-i-74006w207) | COM NEW | 260,000 | $87 million | -25,000 |
| [Celldex Therapeutics Inc New](https://specstream.ai/data/institutional-holders/celldex-therapeutics-inc-new-15117b202) | COM NEW | 2,100,000 | $78.1 million | +1,650,000 |
| [Dianthus Therapeutics Inc](https://specstream.ai/data/institutional-holders/dianthus-therapeutics-inc-252828108) | COM | 800,000 | $78 million | +400,000 |
| [CG Oncology Inc](https://specstream.ai/data/institutional-holders/cg-oncology-inc-156944100) | COM | 1,000,000 | $71.1 million | +425,000 |
| [Disc Medicine Inc](https://specstream.ai/data/institutional-holders/disc-medicine-inc-254604101) | COM | 875,000 | $64 million | +315,000 |
| [Maze Therapeutics Inc](https://specstream.ai/data/institutional-holders/maze-therapeutics-inc-578784100) | COM | 1,935,000 | $57.7 million | +700,000 |
| [Dyne Therapeutics Inc](https://specstream.ai/data/institutional-holders/dyne-therapeutics-inc-26818m108) | COM | 2,550,000 | $56.6 million | +1,150,000 |
| [Moonlake Immunotherapeutics](https://specstream.ai/data/institutional-holders/moonlake-immunotherapeutics-61559x104) | CLASS A ORD | 2,675,000 | $52.1 million | +1,175,000 |
| [Ocular Therapeutix Inc](https://specstream.ai/data/institutional-holders/ocular-therapeutix-inc-67576a100) | COM | 5,300,000 | $52 million | +1,450,000 |
| [Design Therapeutics Inc](https://specstream.ai/data/institutional-holders/design-therapeutics-inc-25056l103) | COM | 3,000,000 | $43.4 million | +1,050,000 |
| [Olema Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/olema-pharmaceuticals-inc-68062p106) | COM | 3,208,875 | $40.1 million | No change |
| [Belite Bio Inc](https://specstream.ai/data/institutional-holders/belite-bio-inc-07782b104) | SPONSORED ADS | 250,000 | $38.5 million | New |
| [Achieve Life Science Inc](https://specstream.ai/data/institutional-holders/achieve-life-science-inc-004468500) | COM | 5,425,000 | $35.4 million | New |
| [Trevi Therapeutics Inc](https://specstream.ai/data/institutional-holders/trevi-therapeutics-inc-89532m101) | COM | 1,880,000 | $35.1 million | -520,000 |
| [Cogent Biosciences Inc](https://specstream.ai/data/institutional-holders/cogent-biosciences-inc-19240q201) | COM | 900,000 | $34.8 million | New |
| [Arrivent Biopharma Inc](https://specstream.ai/data/institutional-holders/arrivent-biopharma-inc-04272n102) | COM | 1,000,000 | $34.7 million | +650,000 |
| [Crescent Biopharma Inc.](https://specstream.ai/data/institutional-holders/crescent-biopharma-inc-g2545c104) | COM | 1,900,000 | $34.2 million | +1,417,500 |
| [Compass Pathways PLC](https://specstream.ai/data/institutional-holders/compass-pathways-plc-20451w101) | SPONSORED ADS | 2,250,000 | $31.8 million | New |

## New positions in Q2 2026

25 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Biontech Se](https://specstream.ai/data/institutional-holders/biontech-se-09075v102) | SPONSORED ADS | 1,015,000 | $94.4 million |
| [Vera Therapeutics Inc](https://specstream.ai/data/institutional-holders/vera-therapeutics-inc-92337r101) | CL A | 2,200,000 | $94.4 million |
| [Belite Bio Inc](https://specstream.ai/data/institutional-holders/belite-bio-inc-07782b104) | SPONSORED ADS | 250,000 | $38.5 million |
| [Achieve Life Science Inc](https://specstream.ai/data/institutional-holders/achieve-life-science-inc-004468500) | COM | 5,425,000 | $35.4 million |
| [Cogent Biosciences Inc](https://specstream.ai/data/institutional-holders/cogent-biosciences-inc-19240q201) | COM | 900,000 | $34.8 million |
| [Compass Pathways PLC](https://specstream.ai/data/institutional-holders/compass-pathways-plc-20451w101) | SPONSORED ADS | 2,250,000 | $31.8 million |
| [Mineralys Therapeutics Inc](https://specstream.ai/data/institutional-holders/mineralys-therapeutics-inc-603170101) | COM | 1,050,000 | $28.3 million |
| [Replimune Group Inc](https://specstream.ai/data/institutional-holders/replimune-group-inc-76029n106) | COM | 2,500,000 | $27.7 million |
| [Summit Therapeutics Inc](https://specstream.ai/data/institutional-holders/summit-therapeutics-inc-86627t108) | COM | 1,350,000 | $19.7 million |
| [Crispr Therapeutics AG](https://specstream.ai/data/institutional-holders/crispr-therapeutics-ag-h17182108) | NAMEN AKT | 300,000 | $16.4 million |
| [DBV Technologies S a](https://specstream.ai/data/institutional-holders/dbv-technologies-s-a-23306j309) | SPONSORED ADS | 915,000 | $15 million |
| [Parabilis Medicines Inc](https://specstream.ai/data/institutional-holders/parabilis-medicines-inc-698955101) | COM | 525,000 | $14.4 million |
| [Scholar Rock HLDG Corp](https://specstream.ai/data/institutional-holders/scholar-rock-hldg-corp-80706p103) | COM | 200,000 | $11 million |
| [Q32 Bio Inc](https://specstream.ai/data/institutional-holders/q32-bio-inc-746964105) | COM | 800,000 | $10.2 million |
| [Odyssey Therapeutics Inc](https://specstream.ai/data/institutional-holders/odyssey-therapeutics-inc-67613t104) | COMMON STOCK | 521,736 | $9.8 million |
| [Annexon Inc](https://specstream.ai/data/institutional-holders/annexon-inc-03589w102) | COM | 1,500,000 | $8.6 million |
| [Editas Medicine Inc](https://specstream.ai/data/institutional-holders/editas-medicine-inc-28106w103) | COM | 2,222,000 | $7.2 million |
| [Cybin Inc](https://specstream.ai/data/institutional-holders/cybin-inc-23256x407) | COM NEW | 750,000 | $5 million |
| [Onkure Therapeutics Inc](https://specstream.ai/data/institutional-holders/onkure-therapeutics-inc-68277q105) | COM CL A | 963,855 | $4.4 million |
| [Definium Therapeutics Inc](https://specstream.ai/data/institutional-holders/definium-therapeutics-inc-24477v105) | COM SHS | 80,000 | $3.8 million |
| [Uniqure NV](https://specstream.ai/data/institutional-holders/uniqure-nv-n90064101) | SHS | 30,000 | $1.4 million |
| [Jatt II Acquisition Corp](https://specstream.ai/data/institutional-holders/jatt-ii-acquisition-corp-g50765109) | ORD SHS | 100,000 | $1.1 million |
| [Research Alliance Corp III](https://specstream.ai/data/institutional-holders/research-alliance-corp-iii-g75226103) | ORD SHS CL A | 100,000 | $1.1 million |
| [Longeveron Inc](https://specstream.ai/data/institutional-holders/longeveron-inc-54303l203) | CL A NEW | 1,287,000 | $904,761 |
| [Amanat Acquisition Corp](https://specstream.ai/data/institutional-holders/amanat-acquisition-corp-g0375m101) | CL A ORD | 50,000 | $508,000 |

## Positions exited in Q2 2026

23 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Centessa Pharmaceuticals PLC | SPONSORED ADS | 2,125,000 | $84.4 million |
| Terns Pharmaceuticals Inc | COM | 1,500,000 | $79.1 million |
| [Cytokinetics Inc](https://specstream.ai/data/institutional-holders/cytokinetics-inc-23282w605) | COM NEW | 875,000 | $57.7 million |
| [United Therapeutics Corp Del](https://specstream.ai/data/institutional-holders/united-therapeutics-corp-del-91307c102) | COM | 80,000 | $47.4 million |
| [Madrigal Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/madrigal-pharmaceuticals-inc-558868105) | COM | 85,000 | $44.5 million |
| [Biogen Inc](https://specstream.ai/data/institutional-holders/biogen-inc-09062x103) | COM | 200,000 | $36.7 million |
| [Tyra Biosciences Inc](https://specstream.ai/data/institutional-holders/tyra-biosciences-inc-90240b106) | COM | 850,000 | $32.6 million |
| Terns Pharmaceuticals Inc | COM (call) | 500,000 | $26.4 million |
| Enliven Therapeutics Inc | COM (call) | 500,000 | $19.6 million |
| [Newamsterdam Pharma Company](https://specstream.ai/data/institutional-holders/newamsterdam-pharma-company-n62509109) | ORDINARY SHARES | 600,000 | $19.2 million |
| [Mirum Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/mirum-pharmaceuticals-inc-604749101) | COM | 200,000 | $18.5 million |
| [Vaxcyte Inc](https://specstream.ai/data/institutional-holders/vaxcyte-inc-92243g108) | COM | 300,000 | $17.4 million |
| [Compass Therapeutics Inc](https://specstream.ai/data/institutional-holders/compass-therapeutics-inc-20454b104) | COM | 3,150,000 | $16.7 million |
| Avalo Therapeutics Inc | COM NEW (call) | 1,000,000 | $14.9 million |
| [Janux Therapeutics Inc](https://specstream.ai/data/institutional-holders/janux-therapeutics-inc-47103j105) | COM | 1,000,000 | $13.9 million |
| [Alkermes PLC](https://specstream.ai/data/institutional-holders/alkermes-plc-g01767105) | SHS | 350,000 | $12.4 million |
| [Oric Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/oric-pharmaceuticals-inc-68622p109) | COM | 950,000 | $12 million |
| Soleno Therapeutics Inc | COM | 250,000 | $8.4 million |
| [Corvus Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/corvus-pharmaceuticals-inc-221015100) | COM | 450,000 | $6.6 million |
| [Meiragtx Hldgs PLC](https://specstream.ai/data/institutional-holders/meiragtx-hldgs-plc-g59665102) | COM | 700,000 | $6.1 million |
| [Verastem Inc](https://specstream.ai/data/institutional-holders/verastem-inc-92337c203) | COM NEW | 1,000,000 | $5.3 million |
| [Ibio Inc](https://specstream.ai/data/institutional-holders/ibio-inc-451033708) | COM NEW | 1,300,000 | $2.5 million |
| [Pharvaris N V](https://specstream.ai/data/institutional-holders/pharvaris-n-v-n69605108) | COM | 65,000 | $1.8 million |

## Also on SpecStream

- [Logos Global Management LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1792126/000117266126003529/0001172661-26-003529-index.htm)
- [Logos Global Management LP investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/logos-global-management-l-p-305162)
- [Largest 13F filers in California](https://specstream.ai/data/institutional-holdings/state/california)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in San Francisco, California

- [Business law firms in San Francisco, California](https://specstream.ai/data/businesses/business-law-firms/san-francisco-california-united-states)
- [Asian restaurants in San Francisco, California](https://specstream.ai/data/businesses/asian-restaurants/san-francisco-california-united-states)
- [Vegetarian restaurants in San Francisco, California](https://specstream.ai/data/businesses/vegetarian-restaurants/san-francisco-california-united-states)
- [Seafood restaurants in San Francisco, California](https://specstream.ai/data/businesses/seafood-restaurants/san-francisco-california-united-states)
- [Private schools in San Francisco, California](https://specstream.ai/data/businesses/private-schools/san-francisco-california-united-states)
- [Orthodontics practices in San Francisco, California](https://specstream.ai/data/businesses/orthodontics-practices/san-francisco-california-united-states)
